COCRYSTAL PHARMA, INC. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
COCRYSTAL PHARMA, INC. (COCP) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $139.24 thousand as of 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2014-03-31
- 2013-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $139.24K.
- 2013-09-30: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $181.72K.
- 2012-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $835.00K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2013-12-31 | $139.24K 10-K · filed 2014-03-31 |
| 2013-09-30 | $181.72K 10-Q · filed 2013-11-18 |
| 2012-12-31 | $835.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |